Predictive Oncology approves 1-for-15 reverse stock split to meet Nasdaq bid price

Axe Compute Inc.

Stockholders approved 1:15 reverse split on Sep 19, 2025; effective Sep 30, 2025.
Post-split shares ~762,414, down from 11,436,201; fractional shares rounded up.
Split intended to bring POAI into compliance with Nasdaq minimum bid price requirement.
Standby Equity Purchase Agreement to issue up to $10M in common stock also approved by shareholders.

item 3.03 item 5.03 item 5.07 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Axe Compute Inc.: Approved and filed Certificate of Amendment to the Charter to effect a 1-for-15 reverse stock split of common stock, effective 5:00 PM ET on September 29, 2025 (effective 2025-09-29).

Change: charter amendment
Effective: 2025-09-29

Exact text from the filing

the Company filed a Certificate of Amendment to the Charter with the Secretary of State of the State of Delaware on September 22, 2025, to effect the reverse stock split, effective as of 5:00 PM ET on September 29, 2025

View on SEC.gov

37 governance changes filed in the last 30 days. Browse all governance changes →

Axe Compute Inc. filing history →

Source: SEC EDGAR

accession 0001171843-25-006069

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.